SRRK
Scholar Rock Holding Corporation
NASDAQ · Healthcare · Biotechnology · US
$55.41
−0.95%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-161.0%
Return on equity
-78.0%
Return on assets
-88.8%
Return on invested capital
0.00x
Asset turnover
-$296.2M
Cash from operations
$4.04
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026